211 related articles for article (PubMed ID: 29914979)
1. Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia.
Dai J; Madeeva D; Hayes V; Ahn HS; Tutwiler V; Arepally GM; Cines DB; Poncz M; Rauova L
Blood; 2018 Aug; 132(7):727-734. PubMed ID: 29914979
[TBL] [Abstract][Full Text] [Related]
2. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.
Johnston I; Sarkar A; Hayes V; Koma GT; Arepally GM; Chen J; Chung DW; López JA; Cines DB; Rauova L; Poncz M
Blood; 2020 Apr; 135(15):1270-1280. PubMed ID: 32077913
[TBL] [Abstract][Full Text] [Related]
3. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
4. Role of monocytes and endothelial cells in heparin-induced thrombocytopenia.
Madeeva D; Cines DB; Poncz M; Rauova L
Thromb Haemost; 2016 Oct; 116(5):806-812. PubMed ID: 27487857
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
6. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
Rauova L; Zhai L; Kowalska MA; Arepally GM; Cines DB; Poncz M
Blood; 2006 Mar; 107(6):2346-53. PubMed ID: 16304054
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.
Horne MK; Hutchison KJ
Am J Hematol; 1998 May; 58(1):24-30. PubMed ID: 9590145
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia.
Rauova L; Hirsch JD; Greene TK; Zhai L; Hayes VM; Kowalska MA; Cines DB; Poncz M
Blood; 2010 Dec; 116(23):5021-31. PubMed ID: 20724543
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
10. Platelet and monocyte antigenic complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).
Rauova L; Arepally G; McKenzie SE; Konkle BA; Cines DB; Poncz M
J Thromb Haemost; 2009 Jul; 7 Suppl 1(0 1):249-52. PubMed ID: 19630810
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.
Newman PM; Chong BH
Blood; 2000 Jul; 96(1):182-7. PubMed ID: 10891449
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
[TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.
Krauel K; Fürll B; Warkentin TE; Weitschies W; Kohlmann T; Sheppard JI; Greinacher A
J Thromb Haemost; 2008 Dec; 6(12):2160-7. PubMed ID: 18983520
[TBL] [Abstract][Full Text] [Related]
14. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
15. Absolute immature platelet counts in the setting of suspected heparin-induced thrombocytopenia may predict anti-PF4-heparin immunoassay testing results.
Chen W; Ha JP; Hong H; Maitta RW
Transfus Apher Sci; 2018 Aug; 57(4):507-511. PubMed ID: 29661682
[TBL] [Abstract][Full Text] [Related]
16. Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT.
Kowalska MA; Krishnaswamy S; Rauova L; Zhai L; Hayes V; Amirikian K; Esko JD; Bougie DW; Aster RH; Cines DB; Poncz M
Blood; 2011 Sep; 118(10):2882-8. PubMed ID: 21772054
[TBL] [Abstract][Full Text] [Related]
17. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
[TBL] [Abstract][Full Text] [Related]
18. Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.
Tutwiler V; Madeeva D; Ahn HS; Andrianova I; Hayes V; Zheng XL; Cines DB; McKenzie SE; Poncz M; Rauova L
Blood; 2016 Jan; 127(4):464-72. PubMed ID: 26518435
[TBL] [Abstract][Full Text] [Related]
19. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
Visentin GP; Ford SE; Scott JP; Aster RH
J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
[TBL] [Abstract][Full Text] [Related]
20. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
